Active, not recruitingNot applicableNCT06202274

Clinical Study to Evaluate the Safety and Efficacy of Candela Technology

Studying Anterior cutaneous nerve entrapment syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Candela Corporation
Principal Investigator
Konika P Schallen, MD
Candela Institue for Exellence
Intervention
Nordlys, Gentle, Picoway, Vbeam, Profound, Profound Matrix, eTwo, Exceed, CO2RE(device)
Enrollment
500 enrolled
Eligibility
18 years · All sexes
Timeline
20232029

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06202274 on ClinicalTrials.gov

Other trials for Anterior cutaneous nerve entrapment syndrome

Additional recruiting or active studies for the same condition.

See all trials for Anterior cutaneous nerve entrapment syndrome

← Back to all trials